Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide (2003)
- Authors:
- USP affiliated authors: HEGG, ROBERTO - FM ; MARANHAO, RAUL CAVALCANTE - FCF
- Unidades: FM; FCF
- Assunto: LIPOPROTEÍNAS
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: American Society of Clinical Oncology
- Volume/Número/Paginação/Ano: v. 22, p. 146, res. 584, 2003
- Conference titles: Annual Meeting of the American Society of Clinical Oncology
-
ABNT
HEGG, Roberto et al. Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. Chicago: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 28 abr. 2024. , 2003 -
APA
Hegg, R., Carvalho, J., Graziani, S., Valduga, C. J., Fernandes, D. C., Azevedo, C. H. M., et al. (2003). Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. Chicago: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Hegg R, Carvalho J, Graziani S, Valduga CJ, Fernandes DC, Azevedo CHM, Lopes AC, Rodrigues DG, Maranhão RC. Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. 2003 ; 22 146.[citado 2024 abr. 28 ] -
Vancouver
Hegg R, Carvalho J, Graziani S, Valduga CJ, Fernandes DC, Azevedo CHM, Lopes AC, Rodrigues DG, Maranhão RC. Use of cholesterol-rich microemulsion that binds to low-density lipotein (LDL) receptors as avehicle for etoposide. American Society of Clinical Oncology. 2003 ; 22 146.[citado 2024 abr. 28 ] - Transfer of lipids to HDL in patients with breast cancer
- One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults
- One hour infusion of clodronate disodium for treating oncological pain due to bone metastases of solid tumors among adults
- Safety and feasibility of neoadjuvant combined chemotherapy of breast cancer with paclitaxel carried in a lipid nanoemulsion (LDE) associated with adriamycin and cyclophosphamide
- Avaliação de captação de uma emulsão lipídica semelhante a LDL em carcinoma de mama
- Use of cholesterol-rich nanoparticles that bind to lipoprotein receptors as a vehicle to paclitaxel in the treatment of breast cancer: pharmacokinetics, tumor uptake and a pilot clinical study
- Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemotherapy
- A lipidic microemulsion that binds to LDL receptors abolishes the side effects of high doses of a chemotherapeutic agent
- Uptake of a cholesterol-rich emulsion by breast cancer
- Uptake by breast carcinoma of a lipidic nanoemulsion after intralesional injection into the patients: a new strategy for neoadjuvant chemothrapy
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
